Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-22-025833
Filing Date
2022-11-30
Accepted
2022-11-30 07:31:25
Documents
66
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 6-K rnlx-20221130.htm   iXBRL 6-K 1601378
  Complete submission text file 0000950170-22-025833.txt   7631148

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnlx-20221130.xsd EX-101.SCH 73747
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnlx-20221130_cal.xml EX-101.CAL 63090
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnlx-20221130_pre.xml EX-101.PRE 410891
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnlx-20221130_def.xml EX-101.DEF 255733
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnlx-20221130_lab.xml EX-101.LAB 577738
60 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20221130_htm.xml XML 1328295
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39387 | Film No.: 221434316
SIC: 8071 Services-Medical Laboratories